Response
- PMID: 24771873
- PMCID: PMC4677262
- DOI: 10.1093/jnci/dju081
Response
Figures
Comment on
-
Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.J Natl Cancer Inst. 2013 Oct 16;105(20):1534-9. doi: 10.1093/jnci/djt248. Epub 2013 Oct 3. J Natl Cancer Inst. 2013. PMID: 24092918
-
RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection.J Natl Cancer Inst. 2014 Apr 26;106(5):dju079. doi: 10.1093/jnci/dju079. J Natl Cancer Inst. 2014. PMID: 24771874 No abstract available.
References
-
- Chou R, Croswell JM, Dana T. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(11):762–771. - PubMed
-
- Haines IE, Miklos GLG. Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection. J Natl Cancer Inst. 2013; 105(20):1534–1539. - PubMed
-
- Haines IE, Miklos GLG. Re: prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection. Response to Walsh. JNCI J Natl Cancer Inst (2014). 106 (2) djt433 10.1093/jnci/djt433. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
